Navigation Links
Valencell, Inc. Selected as 'Showcase Company' at CED Tech Venture Conference 2014
Date:9/16/2014

RALEIGH, N.C., Sept. 16, 2014 /PRNewswire/ -- Valencell, Inc., a leader in performance biometric data sensor technology, has been chosen as one of 18 "Showcase Companies" representing North Carolina's hottest emerging technology businesses at the annual CED Tech Venture Conference on September 16-17th at the Raleigh Convention Center in Raleigh, North Carolina. Valencell's President Dr. Steven LeBoeuf will lead a discussion during the "Digital Health Spotlight Sector" on how the Company's internationally respected biometric technology, Valencell PerformTek, powers wearables with highly accurate, continuous heart rate monitoring during even the most aggressive physical exercise.

Showcase companies are given six minutes to tell their story in front of 600 attendees at a conference that has become a "Who's Who" of the nation's technology industry, from the most exciting emerging tech companies to the most influential investors and tech leaders. Dr. LeBoeuf will discuss biometric wearable technology and how this technology is fueling a myriad of new products in various form factors.

There has been an increasing demand for Valencell PerformTek® biometrics, which powers the most accurate wearables for measuring continuous heart rate during exercise. Leading brands including Jabra, Intel and LG, have licensed PerformTek biometrics for integration into their products, which is available in multiple form factors and is used by more product brands than any other biometric technology.

About Valencell
Founded in 2006 and headquartered in Raleigh, North Carolina, Valencell develops performance biometric data sensors and licenses its patent-protected technology to consumer electronics manufacturers, mobile device and accessory makers, sports and fitness brands and gaming companies for integration into their products. Valencell's PerformTek-powered sensors are the most accurate wearable biometric sensors that continuously measure heart rate and activity. Valencell has invested years into research and development of its PerformTek sensors, which have been validated by the Duke Center for Living, North Carolina State University, the Human Performance Laboratory and a fellow of the American College of Sports Medicine.


'/>"/>
SOURCE Valencell
Copyright©2014 PR Newswire.
All rights reserved

Related biology news :

1. Fred Baxendale selected as Honorary Member of the Entomological Society of America
2. Caswell selected for Mindel C. Sheps award
3. Elsevier selected publish official journal: Engineering in Agriculture, Environment & Food
4. Top 12 Pioneer Awards for seminal work in gene and cell therapy selected by blue ribbon panel
5. Projecis Cloud-based Collaboration Platform Selected by Spaulding Clinical to Manage Phase I Clinical Trial Projects and Timelines
6. Stepping up the Pace: 20th International AIDS Conference (AIDS 2014) theme selected
7. Fred Hutch evolutionary geneticist Harmit Malik selected as an HHMI investigator
8. Conference Programme Committees selected for the 20th International AIDS Conference (AIDS 2014)
9. Desert Research Institute scientist selected to help guide next USGS, NASA Landsat Mission
10. BONESUPPORT Selected As A 2012 Red Herring Top 100 Global
11. The IPCC Report on Climate Change - Swedish professor Thomas Sterner selected as 1 of the experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2018)... ... October 11, 2018 , ... Better lives through a ... for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The Institute, a public-private partnership launched in ... and workforce development in the United States. Biopharmaceuticals are important because they treat ...
(Date:10/5/2018)... ... ... EDETEK, the premier provider of digital clinical trial platforms, today announced that the ... 8-12, 2018. EDETEK is also a Gold Sponsor of the Bay-area Biotech (pharma) Statistics ... are global events held annually on three continents with hundreds of attendees gathering to ...
(Date:10/3/2018)... ... October 03, 2018 , ... ... discovery, development and commercialization of first-in-class stromal cell immunotherapies, announced that ORBCEL-M™, ... with type 2 diabetes and progressive diabetic kidney disease in a four-site, ...
Breaking Biology News(10 mins):
(Date:9/24/2018)... ... September 24, 2018 , ... ReGrow Helmet , the most ... and most affordable option for hair regrowth in the comfort of one’s home. Early ... 2, 2018. , The sophisticated design and advanced technology of the ReGrow Helmet ...
(Date:9/15/2018)... ... September 14, 2018 , ... Next-generation genomic sequencing is transforming what is ... challenges remain. In the past, the sheer size of genomics data has made sharing ... new data ecosystem developed to advance cures by reducing the technological barriers to data ...
(Date:9/12/2018)... ... September 11, 2018 , ... ... American Association of Feline Practitioners Conference (AAFP) later this month. ... adipose-derived stem cell therapy for the treatment of chronic kidney disease in felines ...
(Date:9/7/2018)... ... September 06, 2018 , ... The Discovery ... a meeting of “The industry’s preeminent event on novel drug targets.” BellBrook Labs’ ... tools to study these emerging targets in a quest to find new treatments ...
Breaking Biology Technology: